This user has not added any information to their profile yet.
JW is a leading clinical stage biotech focusing on bringing the most advanced cell based therapy tratment in China and globally. The COMPANY is established with funding from Juno (a Celgene company) and Wuxi Apptec, and Just completed a $90 MM Series A fund raising. Its lead CART product is in clinical study. I am responsible for all business development and partnership activities.